The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CONVERT: An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS).
 
Corinne Faivre-Finn
Research Funding - AstraZeneca (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Merck
 
Michael Snee
Travel, Accommodations, Expenses - Pfizer
 
Linda Ashcroft
No Relationships to Disclose
 
Wiebke Appel
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim
Travel, Accommodations, Expenses - Amgen
 
Fabrice Barlesi
No Relationships to Disclose
 
Adityanarayan Bhatnagar
No Relationships to Disclose
 
Andrea Bezjak
No Relationships to Disclose
 
Felipe Cardenal
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Lilly
 
Pierre Fournel
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); OSI Pharmaceuticals (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Novartis; Peregrine Pharmaceuticals; Pfizer; Roche
 
Susan Harden
No Relationships to Disclose
 
Cécile Le Pechoux
No Relationships to Disclose
 
Rhona Margaret McMenemin
Consulting or Advisory Role - Astellas Pharma; Bayer
Speakers' Bureau - Astellas Pharma; Bayer
 
Nazia Mohammed
No Relationships to Disclose
 
Mary E.R. O'Brien
Employment - Takeda (I)
Honoraria - MSD; Pfizer; Pierre Fabre
Consulting or Advisory Role - MSD; Pfizer; Pierre Fabre
 
Jason R Pantarotto
No Relationships to Disclose
 
Veerle Surmont
No Relationships to Disclose
 
Jan Van Meerbeeck
No Relationships to Disclose
 
Penella J. Woll
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - Amgen; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Paul Lorigan
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Fiona Helen Blackhall
No Relationships to Disclose